Following its prior report on the clinical success of Mounjaro, Eli Lilly has confirmed a considerable commercial response for the drug in India - the need for effective obesity and diabetes treatment is...
In a HIV prevention milestone, the US Food and Drug Administration (FDA) has approved Gilead Sciences' lenacapavir, a twice-a-year long-acting injection, for adults and adolescents at risk of HIV infection.
The Discovery Park Startup Showcase took centre stage at the London Biotechnology Show 2025, sparking dynamic conversations and real-time feedback between emerging biotech entrepreneurs and seasoned investors.
Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...
With the updated Schedule M guidelines representing significant compliance issues for small and medium pharmaceutical units, the Mysuru pharma industry has taken a joint initiative to try and prepare for it...
Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug Kisunla, blocking access for patients seeking treatment under the country...
In a significant move that intended to improve access diabetes care in India, global pharmaceutical leaders Abbott and MSD Pharmaceuticals have entered into a strategic partnership
Glenmark Pharmaceuticals announced on Wednesday that the US FDA issued a Form 483 with five procedural observations after an inspection of its Monroe Manufacturing Facility in North Carolina...
As the deadline has now passed, a large number of India’s small and mid-sized pharmaceutical manufacturers may be forced to shut down, as they have failed to provide required upgrade plans...
Welcure Drugs & Pharmaceuticals announced on Wednesday that it has finalized a contract with Thailand-based Fortune Sagar Impex Compamy for third-party sourcing and procurement services totaling Rs 517 cr